Results 191 to 200 of about 10,941,841 (309)

Strength through diversity: how cancers thrive when clones cooperate

Molecular Oncology, EarlyView.
Intratumor heterogeneity can offer direct benefits to the tumor through cooperation between different clones. In this review, Kuiken et al. discuss existing evidence for clonal cooperativity to identify overarching principles, and highlight how novel technological developments could address remaining open questions.
Marije C. Kuiken, Maartje Witsen, Emile E. Voest, Krijn K. Dijkstra   +3 more
wiley   +1 more source

Corrigendum to "Efficiency comparison of natural coagulants (Cactus pads and <i>Moringa</i> seeds) for treating textile wastewater (in the case of Kombolcha textile industry)" [Heliyon Volume 11, Issue 4, February 2025, Article e42379]. [PDF]

Heliyon
Worku GD, Abate SN.
europepmc   +1 more source

Newsletter issued (4)

Newsletters issued. A newsletter with the latest news will be sent out to stakeholder groups and published on the website (M 9, M 18, M 27, M 36)
openaire   +1 more source

Detection of circulating tumor DNA in colorectal cancer patients using a methylation‐specific droplet digital PCR multiplex

Molecular Oncology, EarlyView.
We developed a cost‐effective methylation‐specific droplet digital PCR multiplex assay containing tissue‐conserved and tumor‐specific methylation markers. The assay can detect circulating tumor DNA with high accuracy in patients with localized and metastatic colorectal cancer.
Luisa Matos do Canto, Louise Raunkilde, Jan Lindebjerg, Mads Malik Aagaard, Christina Therkildsen, Jakob Kleif, Lars Henrik Jensen, Torben Frøstrup Hansen, Rikke Fredslund Andersen   +8 more
wiley   +1 more source

Corrigendum to "Acute Kidney Injury Duration and 20-Year Risks of CKD and Cardiovascular Disease" [<i>Kidney International Reports</i> Volume 9, Issue 4, April 2024, Pages 817-829]. [PDF]

Kidney Int Rep
Jensen SK, Heide-Jørgensen U, Gammelager H, Birn H, Christiansen CF.   +4 more
europepmc   +1 more source

v. 69, issue 4, October 19, 2001 [PDF]

, 2001

core   +1 more source

Next‐generation proteomics improves lung cancer risk prediction

Molecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj, Clara Frick, Ben Schöttker, Bernd Holleczek, Hermann Brenner   +4 more
wiley   +1 more source

2025 Issue 4 Cover [PDF]

Zhongguo aizheng zazhi

doaj  

Corrigendum to "Going for a stroll on lurasidone: Considerations on an atypical case of acute compartment syndrome of both legs" [Heliyon Volume 9, Issue 4, April 2023, Article e15047]. [PDF]

Heliyon
Bosco L, Russo T, Falzone YM, Butera C, Del Prete A, Mellone R, Del Carro U, Filippi M, Previtali SC.   +8 more
europepmc   +1 more source